Latest News by Industry
ENGLEWOOD, Colo., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) ("Gevo", the "Company", "we", "us" or "our") today announced financial results for the third quarter of 2022 and recent corporate highlights.
Recent Corporate Highlights
2022 Third Quarter Financial Highlights
Management Comment
Commenting on the third quarter of 2022 and recent corporate events, Dr. Patrick R. Gruber, Gevo’s Chief Executive Officer, said “We are moving forward on our NZ-1 site in Lake Preston, South Dakota. Temporary roads are being constructed around the location while significant volumes of dirt are being moved in advance of initial foundation work. We are planning to get as much of this preliminary infrastructure done as possible before winter weather in South Dakota limits consistent access to the site. We are excited to be making visible progress on NZ-1 and we will finalize engineering plans as well as the debt financing package for the project over the next few quarters. Once that is complete, the pace of construction activities are expected to increase significantly."
Net-Zero 1 Status
Following the recent groundbreaking ceremony in Lake Preston, South Dakota, the NZ-1 project is on schedule with initial volumes of SAF expected to be delivered in 2025. NZ-1 is being currently designed to produce approximately 62 million gallons per year ("MGPY") of total hydrocarbon volumes, including 55 MGPY of SAF, which would fulfill part of Gevo's more than 375 MGPY of SAF and hydrocarbon supply agreements. Construction activities at NZ-1 in 2022 are for site preparation purposes and will make the location ready for more substantial construction work that is expected to begin in 2023. In an effort to remain on schedule for a 2025 start-up, Gevo will fund initial construction activities from cash reserves. The Company expects to arrange debt and third-party equity financing in 2023 that, when combined with Gevo's equity contribution, will fully fund NZ-1's construction and commissioning.
The transition to an ethanol-to-SAF design from Gevo’s original isobutanol-to-SAF and isooctane design continues to yield improved output expectations as pre-project planning has been completed through phase 2 of front-end loading work (“FEL-2”). The results of this work, combined with support from the Clean Fuel Production Credit (“CFPC”) that was included in the Inflation reduction Act that was signed into law in August, have led to a forecasted, base-case Project EBITDA3 for NZ-1 to be approximately $300 million per year, a 50% increase from the prior estimate of $200 million per year. The total installed cost for NZ-1, including the capital required for the alcohol-to-jet fuel plant as well as any site development costs, is currently forecasted to be approximately $850 million, a 33% increase from the prior estimate of $640 million. This increase is primarily due to increased steel, equipment, and supply chain costs related to the inflationary environment.
Progress on Key NZ1 Development Milestones
Through year-end 2022:
Through first-half 2023:
Throughout the remainder of 2022 and 2023, Gevo expects to update stockholders about certain key milestones related to the development, financing, and construction of NZ-1 as well as subsequent Net-Zero plants. Updates to those milestones will be found in the Company’s press releases and investor presentations in the Investor Relations section of Gevo’s website.
Third Quarter 2022 Financial Results
Revenue. During the three months ended September 30, 2022, the Company sold 41,791 MMBtu of renewable natural gas ("RNG") from Gevo's RNG Project in Northwest Iowa. Revenue increased $0.2 million during the three months ended September 30, 2022, compared to the three months ended September 30, 2021, which consisted of ethanol and hydrocarbons from the Company's development plant in Luverne, Minnesota (the "Luverne Facility"). In the third quarter of 2022, the Company's RNG production began ramping up resulting in biogas commodity sales of $0.3 million, while the activities at the Luverne Facility were minimized to care and maintenance, as the Company has shifted focus to its Net Zero projects.
Cost of production. Cost of production decreased $2.1 million during the three months ended September 30, 2022, compared to the three months ended September 30, 2021, primarily due to moving the Luverne Facility to care and maintenance status.
Idle facility costs. The Company incurred $2.3 million of idle facility costs during the three months ended September 30, 2022, due to putting Gevo's Luverne Facility into care and maintenance status in the third quarter of 2022. Included in idle facility costs are those costs related to removing flammable and other hazardous items from the site, writing off certain patents related to production at the Luverne Facility and costs related to the workforce adjustments. The Company plans to utilize the Luverne Facility to advance the Company's technology and operational knowledge to help us in achieving operational success as we scale up the production and delivery of SAF for Gevo's customers through the Company's Net-Zero Projects.
Depreciation and amortization. Depreciation and amortization in cost of goods sold increased $0.1 million during the three months ended September 30, 2022, compared to the three months ended September 30, 2021, mainly due to placing the RNG Project assets into service in third quarter of 2022.
Research and development expense. Research and development expense was relatively flat for the three months ended September 30, 2022, compared to the three months ended September 30, 2021. These costs are primarily employee and consultant related expenses, along with some patent and lab supply costs.
Selling, general and administrative expense. Selling, general and administrative expense increased $1.9 million during the three months ended September 30, 2022, compared to the three months ended September 30, 2021, primarily due to increases in personnel costs related to strategic hiring and professional fees, as well as non-cash stock-based compensation which reflects higher amortization expense for the stock awards issued in the prior period with higher market value.
Preliminary stage project costs. Preliminary stage project costs are related to the Company's future Net-Zero Projects and Verity project and consist primarily of employee expenses, preliminary engineering and technical consulting costs. Preliminary stage project costs increased $0.6 million during the three months ended September 30, 2022, compared to the three months ended September 30, 2021, primarily due to increases in personnel costs, consulting and professional fees for the Company's Net Zero Projects and Verity project.
Other operations. Other operations expense increased $1.3 million during the three months ended September 30, 2022, compared to the three months ended September 30, 2021, primarily due to increases in engineering personnel and other non-capitalizable costs for NZ1.
Impairment loss. The Company recorded a $24.7 million impairment loss on long-lived assets, which reduced the carrying value of certain property, plant, and equipment, and a leased right of use ("ROU") asset, at the Agri-Energy segment to its fair value. The impairments recorded to date relate to the determination to suspend production at the Luverne Facility and shift the plant into an idled, care and maintenance status during the third quarter of 2022.
Depreciation and amortization expense. Depreciation and amortization expense increased $0.3 million during the three months ended September 30, 2022, compared to the three months ended September 30, 2021, primarily due to the amortization of the Company's patents.
Loss from operations. Excluding the one-time charge of $24.7 million for impairment, the loss from operations increased by $4.2 million during the three months ended September 30, 2022, compared to the three months ended September 30, 2021, primarily due to the increased activities for the Company's Net Zero platform and Verity projects, as well as non-capitalizable cost for NZ1.
Interest expense. Interest expense increased $0.6 million during the three months ended September 30, 2022, compared to the three months ended September 30, 2021, primarily due to the interest on the RNG bonds and the imputed interest on the Company's RNG related dairy leases, both of which were capitalized into construction in process during the construction phase of Gevo's RNG Project in the previous periods.
Interest and dividend income. Interest and dividend income increased $0.6 million during the three months ended September 30, 2022, compared to the three months ended September 30, 2021, primarily due to the interest earned on the Company's investments.
Other income (expense). Other income (expense) for the three months ended September 30, 2022, consists primarily of losses on disposal of fixed assets.
During the nine months ended September 30, 2022, net cash used for operating activities was $36.8 million compared to $28.7 million for the nine months ended September 30, 2021. Non-cash charges primarily consisted of an impairment loss of $24.7 million, depreciation and amortization of $4.5 million, non-cash interest expense of $2.8 million related to debt issuance costs, stock-based compensation expense of $12.6 million. The net cash outflow from changes in operating assets and liabilities increased $7.9 million, primarily due to an increase of cash outflows of $4.0 million in prepaid expenses and other current assets due to the payments for licensing fees and deposits to secure long-lead equipment power transmission and distribution facilities for NZ1, partially offset by $4.2 million of decreased cash payments for the RNG Project.
Webcast and Conference Call Information
Hosting today’s conference call at 4:30 p.m. ET will be Dr. Patrick R. Gruber, Chief Executive Officer, L. Lynn Smull, Chief Financial Officer, and John Richardson, Director of Investor Relations. They will review Gevo’s financial results and provide an update on recent corporate highlights.
To participate in the live call, please register through the following event weblink: https://register.vevent.com/register/BIc9b140adb9fa4b89a10bb2deaacbece5. After registering, participants will be provided with a dial-in number and pin.
To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/pasbrjrz.
A webcast replay will be available two hours after the conference call ends on November 8, 2022. The archived webcast will be available in the Investor Relations section of Gevo's website at www.gevo.com.
About Gevo
Gevo’s mission is to transform renewable energy and carbon into energy-dense liquid hydrocarbons. These liquid hydrocarbons can be used for drop-in transportation fuels such as gasoline, jet fuel, and diesel fuel, that when burned have potential to yield net-zero greenhouse gas emissions when measured across the full lifecycle of the products. Gevo uses low-carbon renewable resource-based carbohydrates as raw materials, and is in an advanced state of developing renewable electricity and renewable natural gas for use in production processes, resulting in low-carbon fuels with substantially reduced carbon intensity (the level of greenhouse gas emissions compared to standard petroleum fossil-based fuels across their lifecycle). Gevo’s products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions. In addition to addressing the problems of fuels, Gevo’s technology also enables certain plastics, such as polyester, to be made with more sustainable ingredients. Gevo’s ability to penetrate the growing low-carbon fuels market depends on the price of oil and the value of abating carbon emissions that would otherwise increase greenhouse gas emissions. Gevo believes that it possesses the technology and know-how to convert various carbohydrate feedstocks through a fermentation process into alcohols and then transform the alcohols into renewable fuels and materials, through a combination of its own technology, know-how, engineering, and licensing of technology and engineering from Axens North America, Inc., which yields the potential to generate project and corporate returns that justify the build-out of a multi-billion-dollar business.
Gevo believes that Argonne National Laboratory GREET model is the best available standard of scientific based measurement for life cycle inventory or LCI.
Learn more at Gevo’s website: www.gevo.com
Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, including, without limitation, whether our fuel sales agreements are financeable, the timing of our Net-Zero 1 project, our financial condition, our results of operation and liquidity, our business development activities, our Net-Zero Projects, financial projections related to our business, our RNG project, our fuel sales agreements, our plans to develop our business, our ability to successfully develop, construct and finance our operations and growth projects, our ability to achieve cash flow from our planned projects, the ability of our products to contribute to lower greenhouse gas emissions, particulate and sulfur pollution, and other statements that are not purely statements of historical fact These forward-looking statements are made based on the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2021 and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.
Non-GAAP Financial Information
This press release contains financial measures that do not comply with U.S. generally accepted accounting principles (GAAP), including non-GAAP cash EBITDA loss, non-GAAP adjusted net loss and non-GAAP adjusted net loss per share. Non-GAAP cash EBITDA loss excludes depreciation and amortization and non-cash stock-based compensation from GAAP loss from operations. Non-GAAP adjusted net loss and adjusted net loss per share exclude non-cash gains and/or losses recognized in the quarter due to the changes in the fair value of certain of Gevo’s financial instruments, such as warrants, convertible debt and embedded derivatives, from GAAP net loss. Management believes these measures are useful to supplement its GAAP financial statements with this non-GAAP information because management uses such information internally for its operating, budgeting and financial planning purposes. These non-GAAP financial measures also facilitate management’s internal comparisons to Gevo’s historical performance as well as comparisons to the operating results of other companies. In addition, Gevo believes these non-GAAP financial measures are useful to investors because they allow for greater transparency into the indicators used by management as a basis for its financial and operational decision making. Non-GAAP information is not prepared under a comprehensive set of accounting rules and therefore, should only be read in conjunction with financial information reported under U.S. GAAP when understanding Gevo’s operating performance. A reconciliation between GAAP and non-GAAP financial information is provided in the financial statement tables below
1 Cash EBITDA loss is a non-GAAP measure calculated by adding back depreciation andamortization and non-cash stock-based compensation to GAAP loss from operations. A reconciliation of cash EBITDA loss to GAAP loss from operations is provided in the financial statement tables following this release.
2 Adjusted net loss per share is a non-GAAP measure calculated by adding back non-cash gains and/or losses recognized in the quarter due to the changes in the fair value of certain of our financial instruments, such as warrants, convertible debt and embedded derivatives, to GAAP net loss per share. A reconciliation of adjusted net loss per share to GAAP net loss per share is provided in the financial statement tables following this release.
3 Project EBITDA is a non-GAAP financial measure that we define as total operating revenues less total operating expenses for the project.
Gevo, Inc.
Condensed Consolidated Balance Sheets Information
(Unaudited, in thousands, except share and per share amounts) As of September 30,
2022 As of December 31,
2021Assets Current assets Cash and cash equivalents$200,564 $40,833 Marketable securities (current) 222,012 275,340 Restricted cash (current) 1,024 25,032 Accounts receivable, net 352 978 Inventories 4,135 2,751 Prepaid expenses and other current assets 3,635 3,607 Total current assets 431,722 348,541 Property, plant and equipment, net 166,004 139,141 Long-term marketable securities — 64,396 Long-term restricted cash 76,842 70,168 Operating right-of-use assets 1,671 2,414 Finance right-of-use assets 27,012 27,297 Intangible assets, net 7,995 8,938 Deposits and other assets 18,165 5,581 Total assets$729,411 $666,476 Liabilities Current liabilities Accounts payable and accrued liabilities$14,916 $28,288 Operating lease liabilities (current) 430 772 Finance lease liabilities (current) 2,125 3,413 Loans payable - other (current) 158 158 Total current liabilities 17,629 32,631 2021 Bonds payable (long-term) 67,038 66,486 Loans payable - other (long-term) 199 318 Operating lease liabilities (long-term) 1,734 1,902 Finance lease liabilities (long-term) 16,349 17,797 Other long-term liabilities 1,520 87 Total liabilities 104,469 119,221 Stockholders' Equity Common stock, $0.01 par value per share; 500,000,000 and 250,000,000 shares authorized at September 30, 2022, and December 31, 2021, respectively; 237,221,732 and 201,988,662 shares issued and outstanding at September 30, 2022, and December 31, 2021, respectively. 2,372 2,020 Additional paid-in capital 1,254,733 1,103,224 Accumulated other comprehensive loss (2,168) (614)Accumulated deficit (629,995) (557,375)Total stockholders' equity 624,942 547,255 Total liabilities and stockholders' equity$729,411 $666,476
Gevo, Inc.
Condensed Consolidated Statements of Operations Information
(Unaudited, in thousands, except share and per share amounts) Three Months Ended
September 30, Nine Months Ended
September 30, 2022 2021 2022 2021 Revenue and cost of goods sold Ethanol sales and related products, net$— $16 $240 $16 Hydrocarbon revenue — 104 81 463 Renewable natural gas commodity 309 — 309 — Total revenues 309 120 630 479 Cost of production (including stock-based compensation) 318 2,378 5,242 4,896 Idle facility costs 2,330 — 2,330 — Depreciation and amortization 1,250 1,104 3,429 3,374 Total cost of goods sold 3,898 3,482 11,001 8,270 Gross loss (3,589) (3,362) (10,371) (7,791)Operating expenses Research and development expense (including stock-based compensation) 1,562 1,495 4,720 4,205 Selling, general and administrative expense (including stock-based compensation) 11,144 9,287 29,205 17,947 Preliminary stage project costs 915 313 1,736 8,512 Other operations (including stock-based compensation) 1,303 — 3,814 — Impairment loss 24,749 — 24,749 — Loss (gain) on disposal of assets — 183 — 5,137 Depreciation and amortization 407 94 1,144 198 Total operating expenses 40,080 11,372 65,368 35,999 Loss from operations (43,669) (14,734) (75,739) (43,790)Other income (expense) (Loss) gain from change in fair value of derivative warrant liability — 6 16 (4)Interest expense (712) (67) (716) (78)Investment income (loss) 874 233 1,204 354 Gain on forgiveness of SBA loan — — — 641 Other income (expense), net (279) 182 2,615 187 Total other income (expense), net (117) 354 3,119 1,100 Net loss$(43,786) $(14,380) $(72,620) $(42,690)Net loss per share - basic and diluted$(0.19) $(0.07) $(0.34) $(0.22)Weighted-average number of common shares outstanding - basic and diluted 236,649,805 199,341,519 216,255,710 193,739,605
Gevo, Inc.
Condensed Consolidated Statements of Comprehensive Income
(Unaudited, in thousands, except share and per share amounts) Three Months Ended
September 30, Nine Months Ended
September 30, 2022 2021 2022 2021 Net loss$(43,786) $(14,380) $(72,620) $(42,690)Other comprehensive income (loss) Unrealized gain (loss) on available-for-sale securities 88 11 (1,554) (296)Comprehensive loss$(43,698) $(14,369) $(74,174) $(42,986)
Gevo, Inc.
Condensed Consolidated Statements of Stockholders’ Equity Information
(Unaudited, in thousands, except share amounts) For the three months ended September 30, 2022 and 2021 Common Stock Paid-In Capital
Accumulated
Other
Comprehensive
Loss
Accumulated
Deficit
Stockholders’
Equity
Shares Amount June 30, 2022235,165,951 $2,353 $1,249,880 $(2,256) $(586,209) $663,768 Non-cash stock-based compensation— — 4,361 — — 4,361 Issuance of common stock under stock plans, net of taxes2,055,781 19 492 — — 511 Other comprehensive loss— — — 88 — 88 Net loss— — — — (43,786) (43,786)September 30, 2022237,221,732 $2,372 $1,254,733 $(2,168) $(629,995) $624,942 June 30, 2021197,964,476 1,980 1,100,932 (307) (526,482) 576,123 Issuance of common stock and common stock warrants, net of issuance costs— — (162) — — (162)Non-cash stock-based compensation— — 1,880 — — 1,880 Issuance of common stock under stock plans, net of taxes3,915,502 39 (3,711) — — (3,672)Other comprehensive loss— — — 11 — 11 Net loss— — — — (14,380) (14,380)September 30, 2021201,879,978 $2,019 $1,098,939 $(296) $(540,862) $559,800 For the nine months ended September 30, 2022 and 2021 Common Stock Paid-In Capital
Accumulated
Other
Comprehensive
Loss
Accumulated
Deficit
Stockholders’
Equity
Shares Amount December 31, 2021201,988,662 $2,020 $1,103,224 $(614) $(557,375) $547,255 Issuance of common stock and common stock warrants, net of issuance costs33,333,336 333 138,675 — — 139,008 Issuance of common stock upon exercise of warrants4,677 — 3 — — 3 Non-cash stock-based compensation— — 12,625 — — 12,625 Issuance of common stock under stock plans, net of taxes1,895,057 19 206 — — 225 Other comprehensive loss— — — (1,554) — (1,554)Net loss— — — — (72,620) (72,620)September 30, 2022237,221,732 $2,372 $1,254,733 $(2,168) $(629,995) $624,942 December 31, 2020128,138,311 $1,282 $643,269 $— $(498,172) $146,379 Issuance of common stock, net of issuance costs68,170,579 682 456,801 — — 457,483 Issuance of common stock upon exercise of warrants1,866,758 18 1,103 — — 1,121 Non-cash stock-based compensation— — 3,300 — — 3,300 Issuance of common stock under stock plans, net of taxes3,704,330 37 (5,534) — — (5,497)Other comprehensive loss— — — (296) — (296)Net loss— — — — (42,690) (42,690)September 30, 2021201,879,978 $2,019 $1,098,939 $(296) $(540,862) $559,800
Gevo, Inc.
Condensed Consolidated Cash Flow Information
(Unaudited, in thousands) Nine Months Ended September 30, 2022 2021 Operating Activities Net loss$(72,620) $(42,690)Adjustments to reconcile net loss to net cash used in operating activities: Impairment loss 24,749 — Loss on disposal of assets — 5,137 (Gain) on forgiveness of SBA Loans — (641)Stock-based compensation 12,624 5,823 Depreciation and amortization 4,452 3,572 Amortization of marketable securities premium 2,755 — Other noncash (income) expense (153) 77 Changes in operating assets and liabilities: Accounts receivable 626 14 Inventories (338) 150 Prepaid expenses and other current assets, deposits and other assets (8,445) (4,459)Accounts payable, accrued expenses and long-term liabilities (420) 4,324 Net cash used in operating activities (36,770) (28,693)Investing Activities Acquisitions of property, plant and equipment (68,535) (30,955)Acquisition of patent portfolio (10) — Proceeds from sale and maturity of marketable securities 243,817 34,332 Purchase of patents and license — (9,000)Purchase of marketable securities (130,402) (422,362)Net cash provided by (used in) investing activities 44,870 (427,985)Financing Activities Proceeds from issuance of 2021 Bonds — 68,995 Debt and equity offering costs (10,993) (34,919)Proceeds from issuance of common stock and common stock warrants 150,000 487,549 Proceeds from exercise of warrants 3 1,119 Net settlement of common stock under stock plans (285) (5,137)Payment of loans payable - other (112) (98)Payment of finance lease liabilities (4,316) (2,996)Net cash provided by financing activities 134,297 514,513 Net increase (decrease) in cash and cash equivalents 142,397 57,835 Cash, cash equivalents and restricted cash at beginning of period 136,033 78,338 Cash, cash equivalents and restricted cash at end of period$278,430 $136,173
Gevo, Inc.
Reconciliation of GAAP to Non-GAAP Financial Information
(Unaudited, in thousands, except share and per share amounts) Three Months Ended
September 30, Nine Months Ended
September 30, 2022 2021 2022 2021 Non-GAAP Cash EBITDA: Loss from operations$(43,669) $(14,734) $(75,739) $(43,790)Depreciation and amortization 1,657 1,198 4,573 3,572 Stock-based compensation 4,220 4,206 12,165 5,823 Non-GAAP cash EBITDA$(37,792) $(9,330) $(59,001) $(34,395) Non-GAAP Adjusted Net Loss: Net Loss$(43,786) $(14,380) $(72,620) $(42,690)Adjustments: Gain (loss) from change in fair value of derivative warrant liability — (6) (16) 4 Non-GAAP Net Income (Loss)$(43,786) $(14,386) $(72,636) $(42,686)Non-GAAP adjusted net loss per share - basic and diluted$(0.19) $(0.07) $(0.34) $(0.22)Weighted-average number of common shares outstanding - basic and diluted 236,649,805 199,341,519 216,255,710 193,739,605
Investor Relations Contact
+1 720-360-7794
IR@gevo.com